Receipt of Signed Agreement from Albany Associates in Cardiology
New York, NY March 1, 2005 - Daxor Corporation, (AMEX:DXR): a medical instrumentation and biotechnology company, today announced the receipt of a signed agreement from Albany Associates in Cardiology, a division of Prime Care Physicians., P.L.L.C. to obtain a Daxor BVA-100 blood volume analyzer on a trial basis.

Prime Care Physicians, P.L.L.C. is an integrated group of highly qualified, respected primary care physicians, cardiologists, and radiologists practicing throughout the Capital District and surrounding communities. The mission statement of Prime Care Physicians “is to provide state of the art medical care to patients, and be prepared to change before change becomes necessary”.

Dr. Joseph Feldschuh, President and CEO of Daxor, noted that derangement of a patient’s blood volume is a prime disturbance in congestive heart failure patients. Physicians treating these patients are faced with a difficult dilemma in treating these patients with the optimum combination of diuretics and vasodilators. The BVA-100 Blood Volume Analyzer provides a tool that enables a physician to treat congestive heart failure patients with a significantly improved degree of precision.


For more infomation, please contact:
Richard Dunn
Director of Operations
Diane Meegan
Investor Relations